Successful Treatment of Recurrent Clostridioides difficile Infection Using a Novel, Drinkable, Oral Formulation of Fecal Microbiota.|https://dx.doi.org/10.1007/s10620-024-08351-7
Low-risk pneumatosis intestinalis in the pediatric surgical population.|https://dx.doi.org/10.1007/s00383-024-05642-y
A review of fecal microbiota, live-jslm for the prevention of recurrent Clostridioides difficile infection.|https://dx.doi.org/10.1093/ajhp/zxae066
Fecal microbiota transplant on Escherichia-Shigella gut composition and its potential role in the treatment of generalized anxiety disorder: A systematic review.|https://dx.doi.org/10.1016/j.jad.2024.03.088
